Tellgen Corp - Asset Resilience Ratio
Tellgen Corp (300642) has an Asset Resilience Ratio of 8.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Tellgen Corp (300642) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Tellgen Corp's Asset Resilience Ratio has changed over time. See 300642 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Tellgen Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300642 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥171.97 Million | 8.6% |
| Total Liquid Assets | CN¥171.97 Million | 8.60% |
Asset Resilience Insights
- Limited Liquidity: Tellgen Corp maintains only 8.60% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tellgen Corp Industry Peers by Asset Resilience Ratio
Compare Tellgen Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055 |
Medical Devices | 4.92% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 22.31% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
Annual Asset Resilience Ratio for Tellgen Corp (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Tellgen Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 10.39% | CN¥181.75 Million ≈ $26.60 Million |
CN¥1.75 Billion ≈ $255.93 Million |
+4.26pp |
| 2023-12-31 | 6.13% | CN¥103.02 Million ≈ $15.07 Million |
CN¥1.68 Billion ≈ $245.80 Million |
-9.54pp |
| 2022-12-31 | 15.67% | CN¥260.88 Million ≈ $38.17 Million |
CN¥1.66 Billion ≈ $243.60 Million |
-2.43pp |
| 2021-12-31 | 18.10% | CN¥271.35 Million ≈ $39.71 Million |
CN¥1.50 Billion ≈ $219.33 Million |
+0.33pp |
| 2020-12-31 | 17.77% | CN¥243.77 Million ≈ $35.67 Million |
CN¥1.37 Billion ≈ $200.73 Million |
-5.62pp |
| 2019-12-31 | 23.39% | CN¥291.60 Million ≈ $42.67 Million |
CN¥1.25 Billion ≈ $182.40 Million |
+23.89pp |
| 2018-12-31 | -0.50% | CN¥-5.47 Million ≈ $-800.28K |
CN¥1.10 Billion ≈ $161.38 Million |
+0.18pp |
| 2017-12-31 | -0.68% | CN¥-6.37 Million ≈ $-931.69K |
CN¥935.16 Million ≈ $136.84 Million |
-- |
About Tellgen Corp
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more